The use of dry powder inhalers (DPIs) represents a cornerstone in the treatment of chronic pulmonary diseases. However, suboptimal inhalation techniques, including inadequate airflow rates, have been a persistent concern for achieving effective therapeutic outcomes, as many patients remain unaware of their insufficient inhalation performance. As an effective strategy, a digital monitoring system, coupled with dry powder inhalers (DPIs), has emerged to estimate flow profiles and provide inhalation information. The estimation could be further facilitated by the application of artificial intelligence (AI). In this work, a novel digital system to primarily monitor pressure during DPI usage was successfully designed, and advanced machine learning (ML) techniques were then employed to estimate inhalation flow profiles based on the captured data. Four optimal machine learning models were selected for subsequent inhalation parameter prediction, given their superior generalization ability. By using these models, inhalation flow profiles could be successfully estimated, with an excellent accuracy of 97.7% for Peak Inspiratory Flow Rate (PIFR) and 95.2% for inspiratory capacity (IC). In summary, the pressure-based digital monitoring system empowered by AI techniques could be successfully applied to assess inhalation flow profiles with excellent accuracy.
1 June 2025 in International Journal of Pharmaceutics
Pulmonary drug delivery represents a non-invasive and efficient alternative to traditional routes of administration, with benefits including enhanced absorption and better patient adherence. This study focuses on the design of inhalable heparin sodium (HS) particles tailored for managing pulmonary infectious diseases and associated complications like pulmonary thromboembolism. A carrier-free dry powder formulation has been developed using co-jet-milling technique, utilizing magnesium stearate (MgSt) as an excipient to optimize particle properties. MgSt demonstrated the ability to modify particle characteristics, enhance aerosolization performance, and improve formulation stability. Experimental results showed that co-milling with MgSt significantly improved the emitted rate (ER) and emitted fine particle fraction (E-FPF) and stability of the formulation. These findings underscore MgSt's dual functionality in stabilizing and enhancing the aerosolization performance of carrier-free HS formulations for dry powder inhalers (DPIs), presenting an approach for high-dose carrier-free DPI formulation design.